After last year’s upheaval at…
After last year’s upheaval at the CDC’s Advisory Committee on [...]
After last year’s upheaval at the CDC’s Advisory Committee on [...]
Ocugen has reported preliminary phase 2 data on its eye [...]
Italian pharma Alfasigma has penned a 125 million euros ($145 [...]
Hopes were high Wednesday for a billion-dollar megadeal—the kind the [...]
With a White House drug pricing deal done and dusted [...]
Caldera has burst onto the scene with $112.5 million in [...]
The Novo Nordisk Foundation is investing 5.5 billion Danish kroner [...]
Still riding the high of last year’s twice-yearly HIV PrEP [...]
The twisting journey of Pretzel Therapeutics’ top brass appears to [...]
The J.P. Morgan Healthcare Conference is rolling on Tuesday with [...]